Is FBIO or KLRS more profitable?

FBIO runs the higher net margin — FBIO at 163.32% versus KLRS at 0.00%.

How have FBIO and KLRS total returns compared?

Over the past 5 years, FBIO delivered -46.06% and KLRS delivered -81.13% annualized total return. Past performance doesn't predict future results.

Fortress Biotech, Inc. (FBIO) vs Kalaris Therapeutics Inc (KLRS)

A side-by-side comparison of Fortress Biotech, Inc. and Kalaris Therapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

FBIO

Fortress Biotech, Inc.

$68M

$2.04HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT

KLRS

Kalaris Therapeutics Inc

$63M

$2.91HealthcareDelayed quote: Oct 6, 2026, 10:37 AM EDT

Total return — FBIO vs KLRS

growth of $100 · dividends reinvested · last 10y

FBIO -95.1% (-26.1%/yr)KLRS -99.1% (-37.3%/yr)FBIO compounded faster over this window

Log scale — wide-divergence pair

FBIO KLRS

FBIO vs KLRS: by the numbers

•FBIO is the larger company ($68M vs $63M market cap).
•FBIO is profitable (163.32% net margin) while KLRS runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	FBIO	KLRS
P/E ratio	0.76	N/A
P/S ratio	0.99	N/A
P/B ratio	0.41	1.10
FCF yield	186.15%	N/A

Profitability

Metric	FBIO	KLRS
Gross margin	62.53%	0.00%
Operating margin	-111.00%	0.00%
Net margin	163.32%	0.00%
ROE	68.12%	-76.75%
ROIC	-10.85%	-52.40%

Growth (annualized)

Metric	FBIO	KLRS
Revenue CAGR (5Y)	5.39%	N/A
Total return CAGR (5Y)	-46.06%	-81.13%

Frequently asked

Is FBIO or KLRS more profitable?: FBIO runs the higher net margin — FBIO at 163.32% versus KLRS at 0.00%.
How have FBIO and KLRS total returns compared?: Over the past 5 years, FBIO delivered -46.06% and KLRS delivered -81.13% annualized total return. Past performance doesn't predict future results.

Go deeper

Full FBIO analysis Full KLRS analysis Interactive comparison tool

Dig into the metrics

Fortress Biotech P/E ratio Fortress Biotech ROE Kalaris Therapeutics ROE Fortress Biotech operating margin Kalaris Therapeutics operating margin Fortress Biotech revenue growth Kalaris Therapeutics revenue growth Fortress Biotech free cash flow Kalaris Therapeutics free cash flow

Fortress Biotech & Kalaris Therapeutics appear in these rankings

Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.